Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaraby Y Nielsen

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cancer Immunology, Immunotherapy : CII|July 11, 2020
Augmenting engineered T-cell strategies in solid cancers through epigenetic primingAaraby Y Nielsen, Maria Ormhøj, Sofie Traynor, et al.
Frontiers in Oncology|February 26, 2021
The Cancer/Testis Antigen Gene <i>VCX2</i> Is Rarely Expressed in Malignancies but Can Be Epigenetically Activated Using DNA Methyltransferase and Histone Deacetylase InhibitorsMie K Jakobsen, Sofie Traynor, Mette Stæhr, et al.
Journal for Immunotherapy of Cancer|September 12, 2022
Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activityOdd L Gammelgaard, Mikkel G Terp, Christian Renn, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 23, 2025
Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibitionMie K Jakobsen, Sofie Traynor, Aaraby Y Nielsen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cancer Immunology, Immunotherapy : CII|July 11, 2020
Augmenting engineered T-cell strategies in solid cancers through epigenetic primingAaraby Y Nielsen, Maria Ormhøj, Sofie Traynor, et al.
Frontiers in Oncology|February 26, 2021
The Cancer/Testis Antigen Gene <i>VCX2</i> Is Rarely Expressed in Malignancies but Can Be Epigenetically Activated Using DNA Methyltransferase and Histone Deacetylase InhibitorsMie K Jakobsen, Sofie Traynor, Mette Stæhr, et al.
Journal for Immunotherapy of Cancer|September 12, 2022
Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activityOdd L Gammelgaard, Mikkel G Terp, Christian Renn, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 23, 2025
Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibitionMie K Jakobsen, Sofie Traynor, Aaraby Y Nielsen, et al.
Pageof 1